baber/WOPTO huggingface dataset:
Patent AU-2002210255-B2 (AU)
Title: Actuator anchor
Inventor: SILVERBROOK KIA
IPC: B41J2/055
Filed: 2001-10-19
Granted: 2004-04-01
Abstract: The invention relates to an ink jet printhead including:a plurality of nozzles mounted to a rigid substrate 26, each of the nozzles being adapted to eject drops of ink toward a surface to be printed;each of the nozzles also having a bend actuator and an apertured roof portion 6, the bend actuator adapted for anchorage to the rigid substrate 26 and connection to the apertured roof portion 6 such that in use the actuator moves the roof portion 6 away from the surface to be printed, in order to eject the ink; wherein,the displacement of all points along the operative section of the bend actuator during its movement from a de-activated to an activated state, constantly increases from zero displacement at the point of anchorage 11 to the rigid substrate 12, 26, to maximum displacement at the point of connection 13 to the apertured roof portion 6.
Patent AU-2002219417-B2 (AU)
Title: Composition and method for potentiating drugs
Inventor: SERDYUK SERGEY
IPC: A61K45/06
Filed: 2001-12-19
Granted: 2007-03-22
Abstract: A method of potentiating the activity of a drug which affects the central nervous system. (CNS) comprising systemically administrating to a subject said drug together with an effective amount of a compound which affects peripheral chemoreceptors and, optionally, with an effective amount of a stimulator of osmoreceptors. Also disclosed are pharmaceutical compositions for systemic administration comprising a CNS drug together with the aforementioned compounds.
Patent AU-2002308030-B2 (AU)
Title: Fibre-enriched table sweeteners
Inventor: SERPELLONI MICHEL
IPC: A23L33/21
Filed: 2002-03-27
Granted: 2007-10-18
Abstract: Fiber-enriched table sweeteners comprise 3-99 wt.% of branched maltodextrins (I) having 15-35% 1-6 glucoside linkages, a reducing sugar content of less than 20%, a polydispersity of less than 5 and a number-average molecular weight (Mn) of up to 4500. <??>An Independent claim is also included for a process for producing the sweeteners, comprising co-spray drying and/or physical mixing of powders.
Patent AU-2002308419-B2 (AU)
Title: Method for mixing a liquid/liquid and/or gaseous media into a solution
Inventor: FOONG WENG CHUEN
IPC: B01F25/46
Filed: 2002-05-22
Granted: 2004-02-26
Abstract: The invention relates to a mechanical device with no moving parts that homogeneously mixes two or more liquids or liquids and gases. It is possible with the device to totally saturate liquids with gas droplets of less than one micron. The device comprises an inlet for partially mixed components leading to a plurality of passageways converging axially into a chamber which has radial openings into another chamber defined by a conical member converging in the axial direction and having an opening at its apex to exit the mixed components, the components exiting the radial openings collide with the walls of the conical member producing shear and turbulence and subsequently spinning within the conical member and are then subjected to increased pressure in the axial direction by the converging wall of the conical member.
Patent AU-2002314629-B2 (AU)
Title: Method of selecting DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
Inventor: OTTE ARIE PIETER
IPC: A61K48/00
Filed: 2002-06-14
Granted: 2007-08-30
Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
Patent AU-2002319049-B2 (AU)
Title: Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
Inventor: AVERBACK PAUL A
IPC: A61P31/04
Filed: 2002-07-19
Granted: 2007-10-25
Abstract: The present invention relates to peptides, compositions, and methods of treating conditions requiring removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using proteins (and peptides derived from the amino acid sequences of such proteins), the amino acid sequence of which includes at least one amino acid sequence derived from neural thread proteins and other related molecules.
Patent AU-2002334592-B2 (AU)
Title: Article carrier having automatic end retention means
Inventor: GARNIER JEAN-MICHEL
IPC: B65D71/12
Filed: 2002-09-18
Granted: 2007-10-11
Abstract: The wrap-around carrier of the invention includes opposed side panels hingedly connected to a top panel and to a pair of bottom flaps. An end retention structure is connected to at least one of the side panels and to the adjacent one of the bottom flaps. The end retention structure includes an anchor panel hingedly connected to an end edge of the one side panel and disposed in a face-contacting relationship with the inside surface of the one side panel, a gusset panel hingedly connected to the anchor panel and extending toward the adjacent end opening of the carrier, and an end panel hingedly connected to the gusset panel and disposed to engage the adjacent end article packaged in the carrier to prevent it from dislodging form the carrier. The end retention structure further includes a relief panel that hingedly interconnects the end panel with the one bottom flap. The relief panel is disposed in the plane of the one bottom flap when the carrier is in an erected condition. When the carrier is in blank form, however, the relief panel is capable of folding with respect to the one bottom flap in response to folding of the anchoring panel onto the one side panel.
Patent AU-2003223636-B2 (AU)
Title: Preformed ankle brace
Inventor: O'HARA MARTIN
IPC: A61F5/01
Filed: 2003-04-15
Granted: 2006-10-05
Abstract: An ankle brace (10), of the type adapted to extend along the lateral and medial aspects of an injured ankle and lower leg for supporting the ankle during healing. A lateral aspects of the ankle and lower leg includes an elongated, rigid support members (13, 14), each having a lower end of sufficiently narrow width and thinness to fit inside a shoe being worn by a wearer of the brace. A soft, flexible perimeter edge portion (15, 16), is to the support members for protecting the leg and ankle from irritation resulting from contact with edges of the support members. A connector (19, 20), connects the medial side support and lateral side support together at their respective lower ends and extend under the foot of the wearer of the brace.
Patent AU-2003251434-B2 (AU)
Title: Method of expressing recombinant protein in CHO cells
Inventor: KALLMEIER ROBERT
IPC: C12N15/90
Filed: 2003-07-21
Granted: 2009-03-05
Abstract: Method for enhancing the transfection rate of a mammalian expression vector in CHO cells.
Patent AU-2003280441-B2 (AU)
Title: Tea manufacture
Inventor: NOBLE IAN
IPC: A23F3/14
Filed: 2003-06-19
Granted: 2006-08-31
Abstract: A method for preparing a fabricated leaf tea product comprises mixing leaf tea with tea solids derived from tea powders, the method being characterised in that the mixture of tea leaves and tea powder is simultaneously wetted with water and dried.
Patent AU-2003294452-B2 (AU)
Title: Method and system for monitoring the location of a vehicle
Inventor: SANQUNETTI DOUGLAS R
IPC: G08G1/123
Filed: 2003-11-21
Granted: 2008-10-02
Abstract: A location of a vehicle is monitored using a predefined geo-fencing boundary within a coordinate system. An angle between a selected straight edge of the boundary and an axis of the coordinate system is determined, and the boundary is rotated by the angle such that the selected straight edge of the rotated boundary is parallel to the axis of the coordinate system. Subsequently, a set of coordinates associated with a particular location of a monitored device are identified and rotated by the previously determined angle. The rotated set of coordinates is then compared to the rotated boundary to determine a location of the monitored device with respect to the selected boundary. This information can be used to determine whether the vehicle remains within the predefined geo-fencing boundary.
Patent AU-2004222051-B2 (AU)
Title: Use of pyridine-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin
Inventor: COLPAERT FRANCIS
IPC: A61K31/445
Filed: 2004-03-15
Granted: 2009-01-15
Abstract: The use of 1-benzoyl-4-(((pyridin-2-ylmethyl)-amino)-methyl)-piperidine derivatives (I) for treating the symptoms of chronic pain of neuropathic or psychogenic origin is new. The use of pyridine derivatives of formula (I), or their mineral or organic acid addition salts, is claimed in the production of medicaments for treating the symptoms of chronic pain of neuropathic or psychogenic origin. [Image] U : H; or may also be Me if V = W = H; V : H or Cl; or may also be Me if U = W = H; W : H or F; or may also be Me if U = V = H; X : H or F; Y : Cl or Me; Z : H, F, Cl or Me; A : H, F, Cl, 1-5C alkyl, fluoroalkyl (e.g. CH 2F, CHF 2, CF 3, CHFMe or CF 2Me), 3-5C cycloalkyl, optionally substituted 5-membered aromatic heterocyclyl containing 1-4 of N, O and/or S as heteroatom(s) (provided that not more than one O and/or S is present), OR 1, SR 1, NR 2R 3, azetidino, pyrrolidino or alkoxycarbonyl (preferably COOMe or COOEt); R 11-5C alkyl, CH 2F, CF 3 or 3-5C cycloalkyl; R 2, R 3H, 1-5C alkyl, CF 3 or cyclopropyl. ACTIVITY : Analgesic. In tests for activity against central neuropathic pain induced by spinal column lesions in rats (see Pain, 1996, 66, 279-286), (3-chloro-4-fluorophenyl)-(4-fluoro-(((5-methyl-pyridin-2-ylmethyl)-amino)-methyl)-piperidin-1-yl)-methanone (Ia) was administered (as the fumarate) at a constant rate of 0.63 mg per day for 14 days using an implanted analgesic pump. Statistically significant analgesia was observed from day 10 of the treatment (demonstrating symptomatic analgesic action); and the analgesia remained at the same level from day 15 after cessation of the treatment for a further 14 days (demonstrating curative analgesic action). MECHANISM OF ACTION : 5-HT-1A receptor agonist.
Patent AU-2004260756-B2 (AU)
Title: Indazole derivatives
Inventor: KIYOI HITOSHI
IPC: C07D231/56
Filed: 2004-07-30
Granted: 2010-03-25
Abstract: The present invention provides a compound represented by Formula (I):    
[whetein R 1  represents CONR 1a R 1b  (wherein R 1a  and R 1b  may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R 1a  and R 1b  are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, 
R 2  represents a hydrogen atom, CONR 2a R 2b  (wherein R 2a  and R 2b  may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R 2a  and R 2b  are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR 2c R 2d  (wherein R 2c  and R 2d  may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].
Patent AU-2004266070-B2 (AU)
Title: Pharmaceutical composition comprising a combination of metformin and a statin
Inventor: JUNIEN JEAN-LOUIS
IPC: A61K31/506
Filed: 2004-08-20
Granted: 2010-03-18
Abstract: A pharmaceutical composition comprising: (i) metformin, optionally in the form of one of its pharmaceutically acceptable salts, (ii) a statin, optionally in the form one of its pharmaceutically acceptable salts, and optionally one or more pharmaceutically acceptable excipients, is suitable for use in the treatment of hyperglycemia non-insulin-dependent diabetes, dyslipidemia, hyperlipidemia, hypercholesterolemia, and obesity.
Patent AU-2005202322-B2 (AU)
Title: Spatially decoupled twin secondary coils for optimizing transcutaneous energy transfer (TET) power transfer characteristics
Inventor: HASSLER WILLIAM L JR
IPC: A61F2/48
Filed: 2005-05-27
Granted: 2010-07-01
Abstract: An implantable device, such as an infuser device for bi-directional hydraulically controlling a medical artificial sphincter, enhances power transfer characteristics to a secondary coil thereby allowing implantation to greater physical depths and/or enclosing the secondary coil within a housing of the infuser device. The enhanced power transfer is achieved with multiple coils that are longitudinally aligned and physical and electrical parallel to form the secondary loop of a transcutaneous energy transfer system (TET) instead of a single coil. It better optimizes the power transfer from a parallel tuned tank circuit primary coil to an implanted secondary series tuned tank circuit coil.
Patent AU-2005235428-B2 (AU)
Title: Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
Inventor: BARBANTI ELENA
IPC: A61K31/40
Filed: 2005-04-19
Granted: 2010-03-18
Abstract: Certain ±-aminoamide derivatives for use in the treatment of addictive disorders are disclosed. The compounds of this invention are able to reduce or even stop the symptoms of addictive disorders substantially without side effects.
Patent AU-2005263406-B2 (AU)
Title: Herbicidal agents
Inventor: ECKHARD ROSE
IPC: A01N43/68
Filed: 2005-06-30
Granted: 2011-10-06
Abstract: Disclosed are herbicide combinations containing an active moiety of components (A) and (B). Component (A) represents one or several herbicides of formula (I) or the salts thereof, wherein R represents H or a group of formula CZZZ, Z, Z, and Z being defined as indicated in claim 1, R and R each represents H, alkyl, haloalkyl, alkenyl, haloalkenyl, alkinyl, haloalkinyl with up to 4 C atoms, respectively, or acyl, R represents H, (C-C)alkyl, or (C-C)alkoxy; R, R, R, and R each represents H, (C-C)alkyl, (C-C)haloalkyl, halogen, (C-C)alkoxy, (C-C)haloalkoxy, or cyano; A represents CH or O or a direct bond, while component (B) represents one or several herbicides from the group of compounds comprising (B1) herbicides that are effective on the ground and are suitable particularly for preemergent application against monocotyl or dicotyl weeds, (B2) herbicides which are effective on leaves and are suitable especially for postemergent application against monocotyl or dicotyl weeds, and (B3) herbicides that are effective on the ground and on leaves and are suitable above all for preemergent or postemergent application against monocotyl or dicotyl weeds. The inventive herbicide combinations are used for controlling weeds.
Patent AU-2005277041-B2 (AU)
Title: Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
Inventor: LEONE-BAY ANDREA
IPC: A61K31/535
Filed: 2005-08-23
Granted: 2012-03-22
Abstract: Biologically active agent delivery compositions, which comprise diketopiperazine carboxylate salts are provided. Related methods for making and using the biologically active agent delivery compositions are also provided.
Patent AU-2006202914-B2 (AU)
Title: Anti-idiotypic antibody neutralizing the inhibitor activity of a factor VIII inhibitor antibody
Inventor: JACQUEMIN MARC G
IPC: A61K39/395
Filed: 2006-07-11
Granted: 2011-08-11
Abstract: The present invention is related to a monoclonal 5 anti-idiotypic antibody directed against a Factor VIII inhibitor antibody binding to the domain A2 of Factor VIII, and to a cell line producing this monoclonal anti-idiotypic antibody, to the use of this monoclonal anti-idiotypic antibody as drug, and 10 more particularly, to its use for the manufacturing of a drug to be used for the treatment of haemophilia H:\jacindat\keep\speci\P61421 SPECIFICATION.doc 11/07/06
Patent AU-2006219583-B2 (AU)
Title: Process for the production of calcium compositions in a continuous fluid bed
Inventor: TOMAS LUNDE KJELL
IPC: A61K31/593
Filed: 2006-03-06
Granted: 2011-11-10
Abstract: The present invention discloses a process for producing a particulate material comprising a calcium-containing compound, the process comprises granulating and/or coating a powder mixture, which comprises the calcium-containing compound together with one or more pharmaceutically acceptable excipients in a continuous fluid bed apparatus.
Patent AU-2006245434-B2 (AU)
Title: Tobacco pouch product
Inventor: HOLLAND TOMMY C
IPC: A24B13/00
Filed: 2006-04-28
Granted: 2012-02-02
Abstract: A pouched tobacco product (100) includes a lined pouch material of a web (130) and a water-soluble liner (120) adjacent the web and a tobacco component (110) contained within the lined pouch material . The water- soluble liner is interposed between the web and the tobacco component. The liner preferably reduces staining of the web by the tobacco component. Additionally, the liner may include a flavorant .
Patent AU-2006248812-B2 (AU)
Title: Antifungal agents
Inventor: EDWARDS PHILIP NEIL
IPC: A61K31/437
Filed: 2006-05-18
Granted: 2012-02-16
Abstract: Compounds of formula (I), and pharmaceutically acceptable salts thereof, may be used in therapy, for example as antifungal agents: (I) wherein: Rl, R2, R3, R4, R5, R6, R7, X and X are as defined herein. Certain compounds of formula (I) are also provided. Compounds of formula (T), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
Patent AU-2006256891-B2 (AU)
Title: Use of the ideS proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
Inventor: LARS BJORCK
IPC: A61P37/06
Filed: 2006-06-08
Granted: 2011-08-04
Abstract: The invention provides use of an IdeS polypeptide, or a polynucleotide encoding an IdeS polypeptide, in the manufacture of a medicament for the treatment or prevention of a disease or condition mediated by IgG antibodies.
Patent AU-2006259478-B2 (AU)
Title: Dental restorative system and components
Inventor: DAVID GARBER
IPC: A61C13/225
Filed: 2006-06-14
Granted: 2011-11-10
Abstract: Disclosed within is a dental restorative system including a dental abutment (100) having a longitudinal axis (119), lingual (141) and facial (142) aspects, a base portion (115) for engagement with a dental implant, and a tapered coronal portion (135). The dental abutment (100) further includes an emergence profile portion (140) between the base portion (115) and the tapered coronal portion (135). The emergence profile portion (140) includes at least a first concave surface (132) and at least a first convex surface (133). The dental abutment (100) may further include an interproximally sloping margin shoulder (150) and a reduced terminal portion (137) located at the upper end of the tapered coronal portion (135). Alternative embodiments of the dental abutment are also disclosed.
Patent AU-2006312373-B2 (AU)
Title: Pharmaceutical combinations comprising testosterone in the treatment of female sexual dysfunction
Inventor: BLOEMERS JOHANNES MARTINUS MARIA
IPC: A61K31/4985
Filed: 2006-11-10
Granted: 2013-01-10
Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analogue thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analogue thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
Patent AU-2006318327-B2 (AU)
Title: Serum-free expansion of cells in culture
Inventor: MICHAEL KAHN
IPC: C12N5/00
Filed: 2006-11-27
Granted: 2011-08-18
Abstract: Methods and agents are disclosed for modulating the interaction of β-catenin or γ-catenin with CBP or p300. Agents that increase the binding of CBP to β-catenin are associated with enhancing the β-catenin related proliferation of adult stem cells, including hematopoietic stem cells, neural stem cells, skin stem cells, and pancreatic stem cells, as well as embryonic stem cells.
Patent AU-2006322362-B2 (AU)
Title: Fixing means for fixing railway lines to sleepers or stretches of track
Inventor: WESTERHOFF KARSTEN
IPC: E01B9/30
Filed: 2006-11-07
Granted: 2010-09-23
Abstract: Fastener has sprung clamp (51) and clamp anchorage (31). Clamp has holding devices which can be put into anchorage in order to be rotatably led along a turning axis. It has at least one pressure strap (52) which, when the sprung clamp is turned around the turning axis, can be brought with the rail foot of the rail (21) into a pre-tensioned position. For holding devices, the sprung clamp has essentially bent clip straps (55,56) and the clamp anchorage has guide means concentric to the turning axis.
Patent AU-2006336552-B2 (AU)
Title: Diagnostic and therapeutic targets for leukemia
Inventor: OKADA YUKI
IPC: C12Q1/68
Filed: 2006-12-06
Granted: 2012-12-20
Abstract: The present invention relates to methods of identifying candidate compounds for the treatment of leukemia and diagnostic methods based on histone methylation and HoxA5 promoter activity.
Patent AU-2006343084-B2 (AU)
Title: Water based emulsion and use thereof
Inventor: SHIBUTANI MITSUO
IPC: C08L29/02
Filed: 2006-04-25
Granted: 2012-12-20
Abstract: A water based emulsion that excels in emulsion polymerization stability at the stage of production and also excels in mechanical stability, freezing stability, long-term neglect stability at high temperature, water-resistant adhesion and re-dispersibility; and a re-dispersible resin and adhesive making use of the water based emulsion. There is provided a water based emulsion comprising polyvinyl alcohol resin (A) of 50 to 2500 average polymerization degree having a 1,2-diol component in side chains thereof and polymer (B) from at least one unsaturated monomer selected from among ethylenically unsaturated monomers and diene monomers.
Patent AU-2007201939-B2 (AU)
Title: Release agent and its use in the production of polyurethane moldings
Inventor: HENNING TORSTEN
IPC: B29C33/56
Filed: 2007-05-01
Granted: 2010-10-07
Abstract: Release agent dispersion (I) for the production of polyurethane molded articles comprises at least a release-active agent from soaps, oils, waxes and silicones; bismuth carboxylate; organic solvent; and optionally usual auxiliary and additives.
Patent AU-2007270844-B2 (AU)
Title: High voltage direct current link transmission system for variable speed wind turbine
Inventor: MAYOR JESUS
IPC: H02P9/00
Filed: 2007-03-16
Granted: 2012-09-27
Abstract: A variable speed wind turbine having a doubly fed induction generator (DFIG), includes an exciter machine (212) mechanically coupled to the DFIG and a power converter (230) placed between a rotor (211) of the DFIG and the exciter machine. Thus, the power converter is not directly connected to the HVDC system (1001, 1002, 1003) avoiding the introduction of undesired harmonic distortion and achieving a better power quality fed. Moreover, the variable speed wind turbine includes a power control and a pitch regulation.